(Q47176304)

11 January 2018

title

Carperitide induces coronary vasodilation and limits infarct size in canine ischemic hearts: role of NO. (English)

1 reference

11 January 2018

author name string

Hiroshi Asanuma

1

1 reference

11 January 2018

Shoji Sanada

2

1 reference

11 January 2018

Masanori Asakura

3

1 reference

11 January 2018

Yoshihiro Asano

4

1 reference

11 January 2018

Jiyoong Kim

5

1 reference

11 January 2018

Yoshiro Shinozaki

6

1 reference

11 January 2018

Hidezo Mori

7

1 reference

11 January 2018

Tetsuo Minamino

8

1 reference

11 January 2018

Seiji Takashima

9

1 reference

11 January 2018

Masafumi Kitakaze

10

1 reference

11 January 2018

publication date

3 April 2014

1 reference

11 January 2018

published in

Hypertension Research

1 reference

11 January 2018

volume

37

1 reference

11 January 2018

issue

8

1 reference

11 January 2018

page(s)

716-723

1 reference

11 January 2018

https://scigraph.springernature.com/pub.10.1038/hr.2014.70

exact match

0 references

cites work

Long-Term Trends in the Incidence of and Survival with Heart Failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Cardiac protection during acute myocardial infarction: where do we stand in 2004?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Translational research of novel hormones: lessons from animal models and rare human diseases for common human diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Natriuretic peptides: an update on bioactivity, potential therapeutic use, and implication in cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

The role of natriuretic peptides in cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Putting the brakes on cardiac hypertrophy: exploiting the NO-cGMP counter-regulatory system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Chronic endothelium-dependent regulation of arterial blood pressure by atrial natriuretic peptide: role of nitric oxide and endothelin-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Beneficial effects of inhibition of angiotensin-converting enzyme on ischemic myocardium during coronary hypoperfusion in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5'-nucleotidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Analysis of nitrate, nitrite, and [15N]nitrate in biological fluids

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Nitric oxide, atrial natriuretic peptide, and cyclic GMP inhibit the growth-promoting effects of norepinephrine in cardiac myocytes and fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Role of nitric oxide in regulation of coronary blood flow during myocardial ischemia in dogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Pharmacological potentiation of natriuretic peptide limits polymorphonuclear neutrophil-vascular cell interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Superoxide anion is involved in the breakdown of endothelium-derived vascular relaxing factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Superoxide dismutase enhances ischemia-induced reactive hyperemic flow and adenosine release in dogs. A role of 5'-nucleotidase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Atrial natriuretic peptide influence on nitric oxide system in kidney and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Role of nitric oxide as a key mediator on cardiovascular actions of atrial natriuretic peptide in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

The therapeutic effect of natriuretic peptides in heart failure; differential regulation of endothelial and inducible nitric oxide synthases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Nitric oxide: a signaling molecule against mitochondrial permeability transition- and pH-dependent cell death after reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Role of cGMP-PKG signaling in the protection of neonatal rat cardiac myocytes subjected to simulated ischemia/reoxygenation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Intravenous administration of the natriuretic peptide urodilatin at low doses during coronary reperfusion limits infarct size in anesthetized pigs

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

Intravenous atrial natriuretic peptide prevents left ventricular remodeling in patients with first anterior acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

7 January 2021

Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction--comparison with nonischemic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

7 January 2021

Antioxidant actions contribute to the antihypertrophic effects of atrial natriuretic peptide in neonatal rat cardiomyocytes

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

7 January 2021

Predominant effect of A-type natriuretic peptide on reduction of oxidative stress during the treatment of patients with heart failure

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

7 January 2021

Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

7 January 2021

The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis

1 reference

https://api.crossref.org/works/10.1038%2FHR.2014.70

7 January 2021

Identifiers

DOI

10.1038/HR.2014.70

1 reference

11 January 2018

PubMed ID

24694647

1 reference

11 January 2018